Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1

H. Shao, L. Cai, James M Grichnik, Alan Livingstone, Omaida C Velazquez, Zhao-Jun Liu

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The tumor microenvironment is emerging as an important target for cancer therapy. Fibroblasts (Fbs) within the tumor stroma are critically involved in promoting tumor growth and angiogenesis through secretion of soluble factors, synthesis of extracellular matrix and direct cell-cell interaction. In this work, we aim to alter the biological activity of stromal Fbs by modulating the Notch1 signaling pathway. We show that Fbs engineered to constitutively activate the Notch1 pathway significantly inhibit melanoma growth and tumor angiogenesis. We determine that the inhibitory effect of Notch-engineered Fbs is mediated by increased secretion of Wnt-induced secreted protein-1 (WISP-1) as the effects of Notch1 activation in Fbs are reversed by shRNA-mediated blockade of WISP-1. When Notch-engineered Fbs are co-grafted with melanoma cells in SCID mice, shRNA-mediated blockade of WISP-1 reverses the tumor-suppressive phenotype of the Notch-engineered Fbs, significantly increases melanoma growth and tumor angiogenesis. Consistent with these findings, supplement of recombinant WISP-1 protein inhibits melanoma cell growth in vitro. In addition, WISP-1 is modestly expressed in melanoma-activated Fbs but highly expressed in inactivated Fbs. Evaluation of human melanoma skin biopsies indicates that expression of WISP-1 is significantly lower in melanoma nests and surrounding areas filled with infiltrated immune cells than in the adjacent dermis unaffected by the melanoma. Overall, our study shows that constitutive activation of the Notch1 pathway confers Fbs with a suppressive phenotype to melanoma growth, partially through WISP-1. Thus, targeting tumor stromal Fbs by activating Notch signaling and/or increasing WISP-1 may represent a novel therapeutic approach to combat melanoma.

Original languageEnglish
Pages (from-to)4316-4326
Number of pages11
JournalOncogene
Volume30
Issue number42
DOIs
StatePublished - Oct 20 2011

Fingerprint

Melanoma
Fibroblasts
Growth
Proteins
Neoplasms
Small Interfering RNA
Phenotype
Tumor Microenvironment
SCID Mice
Dermis
Cell Communication
Extracellular Matrix
Biopsy
Skin
Therapeutics

Keywords

  • fibroblasts
  • melanoma
  • Notch
  • tumor microenvironment
  • WISP-1

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. / Shao, H.; Cai, L.; Grichnik, James M; Livingstone, Alan; Velazquez, Omaida C; Liu, Zhao-Jun.

In: Oncogene, Vol. 30, No. 42, 20.10.2011, p. 4316-4326.

Research output: Contribution to journalArticle

@article{d990e3f7c51440708712225b2506c6fb,
title = "Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1",
abstract = "The tumor microenvironment is emerging as an important target for cancer therapy. Fibroblasts (Fbs) within the tumor stroma are critically involved in promoting tumor growth and angiogenesis through secretion of soluble factors, synthesis of extracellular matrix and direct cell-cell interaction. In this work, we aim to alter the biological activity of stromal Fbs by modulating the Notch1 signaling pathway. We show that Fbs engineered to constitutively activate the Notch1 pathway significantly inhibit melanoma growth and tumor angiogenesis. We determine that the inhibitory effect of Notch-engineered Fbs is mediated by increased secretion of Wnt-induced secreted protein-1 (WISP-1) as the effects of Notch1 activation in Fbs are reversed by shRNA-mediated blockade of WISP-1. When Notch-engineered Fbs are co-grafted with melanoma cells in SCID mice, shRNA-mediated blockade of WISP-1 reverses the tumor-suppressive phenotype of the Notch-engineered Fbs, significantly increases melanoma growth and tumor angiogenesis. Consistent with these findings, supplement of recombinant WISP-1 protein inhibits melanoma cell growth in vitro. In addition, WISP-1 is modestly expressed in melanoma-activated Fbs but highly expressed in inactivated Fbs. Evaluation of human melanoma skin biopsies indicates that expression of WISP-1 is significantly lower in melanoma nests and surrounding areas filled with infiltrated immune cells than in the adjacent dermis unaffected by the melanoma. Overall, our study shows that constitutive activation of the Notch1 pathway confers Fbs with a suppressive phenotype to melanoma growth, partially through WISP-1. Thus, targeting tumor stromal Fbs by activating Notch signaling and/or increasing WISP-1 may represent a novel therapeutic approach to combat melanoma.",
keywords = "fibroblasts, melanoma, Notch, tumor microenvironment, WISP-1",
author = "H. Shao and L. Cai and Grichnik, {James M} and Alan Livingstone and Velazquez, {Omaida C} and Zhao-Jun Liu",
year = "2011",
month = "10",
day = "20",
doi = "10.1038/onc.2011.142",
language = "English",
volume = "30",
pages = "4316--4326",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "42",

}

TY - JOUR

T1 - Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1

AU - Shao, H.

AU - Cai, L.

AU - Grichnik, James M

AU - Livingstone, Alan

AU - Velazquez, Omaida C

AU - Liu, Zhao-Jun

PY - 2011/10/20

Y1 - 2011/10/20

N2 - The tumor microenvironment is emerging as an important target for cancer therapy. Fibroblasts (Fbs) within the tumor stroma are critically involved in promoting tumor growth and angiogenesis through secretion of soluble factors, synthesis of extracellular matrix and direct cell-cell interaction. In this work, we aim to alter the biological activity of stromal Fbs by modulating the Notch1 signaling pathway. We show that Fbs engineered to constitutively activate the Notch1 pathway significantly inhibit melanoma growth and tumor angiogenesis. We determine that the inhibitory effect of Notch-engineered Fbs is mediated by increased secretion of Wnt-induced secreted protein-1 (WISP-1) as the effects of Notch1 activation in Fbs are reversed by shRNA-mediated blockade of WISP-1. When Notch-engineered Fbs are co-grafted with melanoma cells in SCID mice, shRNA-mediated blockade of WISP-1 reverses the tumor-suppressive phenotype of the Notch-engineered Fbs, significantly increases melanoma growth and tumor angiogenesis. Consistent with these findings, supplement of recombinant WISP-1 protein inhibits melanoma cell growth in vitro. In addition, WISP-1 is modestly expressed in melanoma-activated Fbs but highly expressed in inactivated Fbs. Evaluation of human melanoma skin biopsies indicates that expression of WISP-1 is significantly lower in melanoma nests and surrounding areas filled with infiltrated immune cells than in the adjacent dermis unaffected by the melanoma. Overall, our study shows that constitutive activation of the Notch1 pathway confers Fbs with a suppressive phenotype to melanoma growth, partially through WISP-1. Thus, targeting tumor stromal Fbs by activating Notch signaling and/or increasing WISP-1 may represent a novel therapeutic approach to combat melanoma.

AB - The tumor microenvironment is emerging as an important target for cancer therapy. Fibroblasts (Fbs) within the tumor stroma are critically involved in promoting tumor growth and angiogenesis through secretion of soluble factors, synthesis of extracellular matrix and direct cell-cell interaction. In this work, we aim to alter the biological activity of stromal Fbs by modulating the Notch1 signaling pathway. We show that Fbs engineered to constitutively activate the Notch1 pathway significantly inhibit melanoma growth and tumor angiogenesis. We determine that the inhibitory effect of Notch-engineered Fbs is mediated by increased secretion of Wnt-induced secreted protein-1 (WISP-1) as the effects of Notch1 activation in Fbs are reversed by shRNA-mediated blockade of WISP-1. When Notch-engineered Fbs are co-grafted with melanoma cells in SCID mice, shRNA-mediated blockade of WISP-1 reverses the tumor-suppressive phenotype of the Notch-engineered Fbs, significantly increases melanoma growth and tumor angiogenesis. Consistent with these findings, supplement of recombinant WISP-1 protein inhibits melanoma cell growth in vitro. In addition, WISP-1 is modestly expressed in melanoma-activated Fbs but highly expressed in inactivated Fbs. Evaluation of human melanoma skin biopsies indicates that expression of WISP-1 is significantly lower in melanoma nests and surrounding areas filled with infiltrated immune cells than in the adjacent dermis unaffected by the melanoma. Overall, our study shows that constitutive activation of the Notch1 pathway confers Fbs with a suppressive phenotype to melanoma growth, partially through WISP-1. Thus, targeting tumor stromal Fbs by activating Notch signaling and/or increasing WISP-1 may represent a novel therapeutic approach to combat melanoma.

KW - fibroblasts

KW - melanoma

KW - Notch

KW - tumor microenvironment

KW - WISP-1

UR - http://www.scopus.com/inward/record.url?scp=80054926267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054926267&partnerID=8YFLogxK

U2 - 10.1038/onc.2011.142

DO - 10.1038/onc.2011.142

M3 - Article

VL - 30

SP - 4316

EP - 4326

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 42

ER -